ResearcherIran University of Medical SciencesActive in the last 2 years

Hamid Nickho

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0776-1123; OpenAlex author ID A5001237070. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2024: 2 papers

Papers 2

Current and future immunotherapeutic approaches in pancreatic cancer treatment. Co-author DOI 10.1186/s13045-024-01561-6 ↗
High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Pathological Features in Patients with Pancreati… Co-author DOI 10.18502/ijaai.v23i3.15636 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pooya Farhangnia · 1 shared paper, 2024 · strength 0.31
- Paper Current and future immunotherapeutic approaches in pancreatic cancer treatment. DOI 10.1186/s13045-024-01561-6 ↗
Ali‐Akbar Delbandi · 1 shared paper, 2024 · strength 0.31
- Paper Current and future immunotherapeutic approaches in pancreatic cancer treatment. DOI 10.1186/s13045-024-01561-6 ↗
Elahe Safari · 1 shared paper, 2024 · strength 0.24
- Paper High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Patholog… DOI 10.18502/ijaai.v23i3.15636 ↗
Fereshteh Rezagholizadeh · 1 shared paper, 2024 · strength 0.24
- Paper High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Patholog… DOI 10.18502/ijaai.v23i3.15636 ↗
Mohammad Taghi Joghataei · 1 shared paper, 2024 · strength 0.24
- Paper High-expression of V-domain Imuunoglobulin Suppressor of T-cell Activation (VISTA) Is Correlated with Advanced Patholog… DOI 10.18502/ijaai.v23i3.15636 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.